Submissions from 2024
PREDICTORS OF PAP COMPLIANCE ONE MONTH AFTER BARIATRIC SURGERY, Ankita Badhwar, Dania Shakaroun, Seif Bugazia, Arthur M. Carlin, Timothy Roehrs, and Virginia Skiba
IMPROVING ADHERENCE TO SLEEP RESTRICTION IN DIGITAL CBT-I, Alec D. Bayoneto, Marleigh Treger, Cynthia Fellman-Couture, A. Batra, Christopher Drake, and Philip Cheng
SAFETY AND EFFICACY OF KP1077 IN A PHASE 2, DOUBLE-BLIND, RANDOMIZED TRIAL IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA, R. Braeckman, Christopher Drake, D. Gallo, B. Vaughn, and I. AbdelFattah
PAP THERAPY IMPACT ON BARIATRIC SURGERY COMPLICATIONS: A 30-DAY PRE-OPERATIVE EVALUATION, Seif Bugazia, Ankita Badhwar, Dania Shakaroun, Arthur M. Carlin, Timothy Roehrs, and Virginia Skiba
MEASURING SLEEP WITH THE APPLE WATCH: A COMPARISON OF A MACHINE LEARNING VERSUS TRADITIONAL ALGORITHMS TO ACTIWATCH, D. Caputo, Mika Hirata, J. Moreno, Christopher Drake, O. Walch, and Philip Cheng
INSOMNIA IN STATE MEDICAID ADMINISTRATIVE CLAIMS: MISSED OPPORTUNITY FOR IMPLEMENTATION AND DISSEMINATION?, Philip Cheng, S. Clack, Alec D. Bayoneto, Marleigh Treger, Cynthia Fellman-Couture, David Kalmbach, and Christopher Drake
Comparison of demographics and baseline narcolepsy symptoms between participants with NT1 and NT2 from the Phase 3 REST-ON clinical trial, Yves Dauvilliers, Thomas Roth, Michael J. Thorpy, Anne M. Morse, Clete A. Kushida, John Harsh, Luis E. Ortiz, Jordan Dubow, and Jennifer Gudeman
COMPARISON OF DEMOGRAPHICS AND BASELINE NARCOLEPSY SYMPTOMS BETWEEN PARTICIPANTS WITH NT1 AND NT2 FROM REST-ON, Yves Dauvilliers, Thomas Roth, Michael J. Thorpy, Anne M. Morse, Clete A. Kushida, John Harsh, Luis E. Ortiz, and Jennifer Gudeman
DEVELOPMENT OF THE AFFECTIVE NEUROSCIENCE DREAM RATING SCALE, Christopher Drake, Gregory Mahr, Anthony Reffi, Kimberly Son, Grace Seymour, Chaewon Sagong, Lily Jankowiak, Joy Pawirosetiko, Aneesh Hehr, Philip Cheng, David Kalmbach, Thomas Roth, and David A. Moore
SLEEP TIMING AND DEPRESSION RISK IN PREGNANCY, Liana Dunietz, Anna Olson, Lucas Tittle, David Kalmbach, D’Angela Pitts, Chia-Lun Yang, Erica Jansen, Jean Kerver, Kelly A. Hirko, Helen Burgess, Leslie Swanson, and Louise O’Brien
CONSTRUCT VALIDATION OF THE PERINATAL RUMINATION SCALE AT NIGHT IN PREGNANT PATIENTS SEEKING INSOMNIA TREATMENT, David Kalmbach, Mika Hirata, Justin N. Iqal, Alec D. Bayoneto, Philip Cheng, Anthony Reffi, D’Angela Pitts, Leslie Swanson, Jason Ong, David Fresco, Louise O’Brien, and Christopher Drake
Magnitude of improvement in excessive daytime sleepiness with the once-at-bedtime oxybate for narcolepsy, Clete A. Kushida, Michael J. Thorpy, Anne M. Morse, John Harsh, Luis E. Ortiz, Thomas Roth, Yves Dauvilliers, Jordan Dubow, and Jennifer Gudeman
MAGNITUDE OF IMPROVEMENT IN EXCESSIVE DAYTIME SLEEPINESS WITH THE ONCE-AT-BEDTIME OXYBATE FOR NARCOLEPSY, Clete A. Kushida, Michael J. Thorpy, Anne M. Morse, John Harsh, Luis E. Ortiz, Thomas Roth, Yves Dauvilliers, Jordan Dubow, and Jessica Gudeman
UPTAKE OF FULLY AUTOMATED DIGITAL CBT FOR INSOMNIA IN THE HENRY FORD HEALTHCARE SYSTEM: THE FIRST 100 PATIENTS, Christopher Miller, Mika Hirata, Danielle Bradley, Arianna Blaine, Alasdair Henry, Shana Hall, Greig Thomson, Ian Wood, David Kalmbach, and Christopher Drake
Composite response with once-nightly sodium oxybate: symptom improvement in participants with narcolepsy type 1 in REST-ON, Luis E. Ortiz, Thomas Roth, Anne M. Morse, Michael J. Thorpy, John Harsh, Clete A. Kushida, Jordan Dubow, Jennifer Gudeman, and Yves Dauvilliers
COMPOSITE RESPONSE WITH ONCE-NIGHTLY SODIUM OXYBATE: SYMPTOM IMPROVEMENT IN PARTICIPANTS WITH NARCOLEPSY TYPE 1, Luis E. Ortiz, Thomas Roth, Anne M. Morse, Michael J. Thorpy, John Harsh, Clete Kushida, Jennifer Gudeman, and Yves Dauvilliers
PERSONALIZED LIGHT THERAPY FOR NIGHT SHIFT WORK: A PRECISION MEDICINE APPROACH TO REDUCING INSOMNIA AND SLEEPINESS, Grace Paniccia, Salma Habash, Christopher Drake, Olivia Walch, and Philip Cheng
Early identification of patients most vulnerable to acute insomnia after trauma, Anthony Reffi, David Kalmbach, Grace Seymour, Matthew Solway, David A. Moore, Gregory Mahr, and Christopher Drake
Hyperarousal/Sleep Disturbance and Inability to Discontinue Chronic Hypnotic Use, Timothy Roehrs, Gail Koshorek, and Thomas Roth
Effects of oxybate on sleep, sleep architecture, and disrupted nighttime sleep, Thomas Roth, Yves Dauvilliers, Richard Bogan, Giuseppe Plazzi, and Jed Black
Characterization of patients who had ≥5% weight loss with once-nightly sodium oxybate: post hoc analysis from REST-ON, Thomas Roth, Anne M. Morse, Richard Bogan, A. Roy, Jordan Dubow, Jennifer Gudeman, and Yves Dauvilliers
COMPARISON OF BASELINE NARCOLEPSY CHARACTERISTICS AMONG PARTICIPANT AGE GROUPS: ANALYSIS FROM REST-ON, Thomas Roth, Paula Schweitzer, Michael J. Thorpy, Jennifer Gudeman, and Yves Dauvilliers
Application of AASM clinical significance thresholds to once-nightly sodium oxybate for improvement in narcolepsy symptoms, Thomas Roth, Michael J. Thorpy, Clete A. Kushida, Anne M. Morse, Jordan Dubow, Jennifer Gudeman, and Yves Dauvilliers
A PILOT STUDY EXAMINING THE RELATIONSHIP BETWEEN WORK PRODUCTIVITY AND CIRCADIAN MISALIGNMENT IN NIGHT SHIFT WORK, Jonathan Russell, Salma Habash, Christopher Drake, and Philip Cheng
Consistent efficacy of once-nightly sodium oxybate regardless of patient demographic and baseline disease characteristics, Michael J. Thorpy, Thomas Roth, Clete A. Kushida, Anne M. Morse, John Harsh, Luis E. Ortiz, Jordan Dubow, Jennifer Gudeman, and Yves Dauvilliers
CONSISTENT EFFICACY OF ONCE-NIGHTLY SODIUM OXYBATE ACROSS PATIENT DEMOGRAPHIC AND BASELINE DISEASE CHARACTERISTICS, Michael J. Thorpy, Thomas Roth, Clete Kushida, Anne M. Morse, John Harsh, Luis E. Ortiz, Jennifer Gudeman, and Yves Dauvilliers
SOLRIAMFETOL ON COGNITION IN OBSTRUCTIVE SLEEP APNEA WITH EXCESSIVE DAYTIME SLEEPINESS AND IMPAIRED COGNITION, Hans Van Dongen, Eileen Leary, Graham Eglit, Christopher Drake, Richard Bogan, and Judith Jaeger
Effects of solriamfetol on cognition in participants with cognitive impairment associated with excessive daytime sleepiness in obstructive sleep apnea: SHARP study results, Hans P. A. Van Dongen, E. B. Leary, Christopher Drake, Richard Bogan, Judith Jaeger, R. Rosenberg, C. Streicher, H. Kwak, J. Bates, and H. Tabuteau
PRESSURE INJURY OF THE FACE AFTER AN OVERNIGHT TITRATION STUDY, Zaid Yaqoob, Syed Jaffery, and Luisa Bazan
Submissions from 2023
Digital CBT-I versus stepped-care CBT-I to prevent depression one year later, Philip Cheng, David Kalmbach, Chaewon Sagong, Cynthia Fellman-Couture, and Christopher Drake
Effet de la Paroxetine sur le sommeil de patients dépressifs analysé avec Somno-Art et la polysomnographie, Antoine Viola, Laurie Thiesse, Luc Staner, Gil Fuchs, Thomas Roth, Jean-Yves Schaffhausser, Jay Saoud, and Remy Luthringer
Variabilité interscoreurs entre 5 centres de sommeil comparé à une analyse cardio-actimétrique, Antoine Viola, Laurie Thiesse, Luc Staner, Gil Fuchs, Thomas Roth, Jean-Yves Schaffhausser, Jay Saoud, and Remy Luthringer
Submissions from 2022
P689. Improving Treatment Effectiveness in Marginalized Individuals: Facilitators and Barriers to Digital Cognitive Behavioral Therapy for Insomnia, Philip Cheng, Sara Santarossa, David A. Kalmbach, and Christopher L. Drake
Severe multisystem inflammatory response to COVID-19 vaccination, Dania A. Shakaroun and John Buckley
Submissions from 2021
1156 Social determinants of sleep in black pregnant women, D'Angela S. Pitts, Nicolina M. Smith, Mariam Ayyash, and Louise O'Brien
102 The efficacy of a pilot program for obstructive sleep apnea screening in pregnancy, Nicolina Smith, Matthew Floyd, Roopina Sangha, Philip Cheng, Angela Osborne, D'Angela S. Pitts, and Luisa Bazan
Submissions from 2020
Subject-reported perception of long-term effectiveness of lemborexant versus placebo in nonelderly and elderly subgroups, Christopher l. Drake, J Yardley, K Pinner, C Perdomo, and M Moline
Clot distribution in pulmonary embolism does not influence right ventricular recovery, Jennifer Hines, M Floyd, Reem Ismail, Phong Le, Gillian Grafton, Bryan A. Kelly, Sara Hegab, and Rana Awdish
Coupling Continuous Positive Airway Pressure (CPAP) and MR-guided Radiation Therapy, Evan Liang, Eric D. Morris, Jonathan Vono, Luisa Bazan, Mei Lu, Ankit Modh, and Carri K. Glide-Hurst
Submissions from 2019
Risk-taking and circadian misalignment in night shift workers, Philip Cheng, Andrea Cuamatzi-Castelan, and Christopher L. Drake
Efficacy of a stepped-care CBT-I approach for insomnia, Philip Cheng, Cynthia Fellman-Couture, R L. Atkinson, Christine V. Tonnu, Kenneth Moss, and Christopher L. Drake
Comparative efficacy of digital CBT-I versus stepped-care CBT-I to reduce comorbid depression, Philip Cheng, Cynthia Fellman-Couture, R L. Atkinson, Christine V. Tonnu, Meeta Singh, and Christopher L. Drake
Predicting circadian phase in night shift workers using actigraphy, Philip Cheng, O J. Walch, Andrea Cuamatzi-Castelan, and Christopher L. Drake
Insomnia in late pregnancy: Characterizing phenotypes and identifying associated factors, Andrea Cuamatzi-Castelan, David A. Kalmbach, R L. Atkinson, Roopina Sangha, Luisa Bazan, L M. O'Brien, L M. Swanson, Thomas Roth, and Christopher L. Drake
Changes in use of sleep aids following digital cognitive behavioral therapy for insomnia, Christopher L. Drake, Philip Cheng, Gabriel Tallent, R L. Atkinson, Andrea Cuamatzi-Castelan, and Luisa Bazan
Arousability of insomnia patients is not impacted by the orexin antagonist suvorexant (10 mg and 20 mg), Christopher l. Drake, Andrea Cuamatzi-Castelan, David A. Kalmbach, Philip Cheng, Thomas Roth, Meeta Singh, M K. Tran, Christine V. Tonnu, R L. Atkinson, and Cynthia Fellman-Couture
Online medical education improves knowledge of physiologic mechanisms of sleep among neurologists and primary care clinicians, T Finnegan, C F. Murray, S Hughes, and Thomas Roth
Insomniacs in late pregnancy are clinically depressed: Exploring the role of nocturnal rumination, David A. Kalmbach, Andrea Cuamatzi-Castelan, Christine V. Tonnu, Roopina Sangha, L M. O'Brien, L M. Swanson, Thomas Roth, and Christopher L. Drake
Are people with severe insomnia able to discontinue hypnotics after chronic use?, Gail Koshorek, Jelena Verkler, Dana Withrow, Thomas Roth, and Timothy Roehrs
Effects of suvorexant on sleep in fibromyalgia, Gail Koshorek, Jelena Verkler, Dana Withrow, Thomas Roth, and Timothy Roehrs
Idiopathic hypersomnia symptom diary (IHSD): development of a new patient reported outcome (PRO) measure, M C. Lam, A Dorenbaum, L Lien, Thomas Roth, and S D. Mathias
Treatment of obstructive sleep apnea with positive airway pressure to improve cognitive function in mild cognitive impairment, Beth McLellan, Virginia Skiba, Marina Novikova, Lonni R. Schultz, and Aarushi Suneja
Pharmacokinetics and dose proportionality of FT218, an investigational controlled release formulation of sodium oxybate for once nightly dosing, D Monteith, J Grassot, C Castellan, and Thomas Roth
Pharmacokinetics and formulation selection of FT218, an investigational controlledrelease sodium oxybate formulation designed for once nightly dosing, D Monteith, J Grassot, C Castellan, and Thomas Roth
Are reports of mental fog from patients with idiopathic hypersomnia mediated by objective measures of daytime sleepiness?, Thomas Roth, A Dorenbaum, M Jaros, and M Lam
Lemborexant treatment for insomnia in phase 3: Impact on disease severity, Thomas Roth, R Rosenberg, P Murphy, J Yardley, D Kumar, K Pinner, C Perdomo, and M Moline
The impact of lemborexant treatment on insomnia disease severity: results from a pooled analysis of two phase 3 studies, Thomas Roth, R Rosenberg, J Yardley, D Kumar, K Pinner, C Perdomo, and M Moline
Baseline characteristics of idiopathic hypersomnia subjects enrolled in a clinical trial (ARISE2), Thomas Roth, L Rosenthal, A Avidan, N Baio, A Dorenbaum, M Lam, and M Thorpy
Characteristics of subjects excluded form an idiopathic hypersomnia randomized clinical trial (ARISE2), Thomas Roth, L Rosenthal, A Dorenbaum, N Baio, M Lam, and A Avidan
The pharmacokinetics of once-nightly controlled- release Sodium Oxybate (FT218): overview of results from four phase 1 studies, M Thorpy, J Dubow, D Monteith, J Grassot, Thomas Roth, J Winkelman, and B Corser
Polysomnography in insomnia disorder, Jelena Verkler, Gail Koshorek, Thomas Roth, and Timothy Roehrs
Effects of suvorexant on pain sensitivity in fibromyalgia, Dana Withrow, Jelena Verkler, Gail Koshorek, Thomas Roth, and Timothy Roehrs
Submissions from 2018
Efficacy of Cognitive Behavioral Therapy for Insomnia on Post-Menopausal Quality of Life, J T. Arnedt, Philip Cheng, Cynthia Fellman-Couture, G Tallent, David A. Kalmbach, Meeta Singh, Thomas Roth, and Christopher L. Drake
Comparison of Idiopathic Interstitial Pneumonia and Connective Tissue Disease Related Interstitial Lung Disease by Physiologic and Functional Testing Parameters, S K. Avasarala, Sarah Gorgis, Mohammed Dabbagh, A Saeed, C Gondolfo, N Garza, Jeffrey H. Jennings, and Krishna Thavarajah
Digital Cognitive Behavioral Therapy for Insomnia Reduces Incident Depression at Oneyear Follow-Up, Philip Cheng, G Tallent, A Luik, Edward L. Peterson, K Tran, Brian Ahmedani, D Adler, Thomas Roth, and Christopher L. Drake
Applicaiton of Mathematical Modeling for Faster Circadian Tntrainment, Philip Cheng, O Walch, and Christopher L. Drake
Using mathematical modeling to predict circadian phase in night shift workers, Philip Cheng, O Walch, K Tran, Andrea Cuamatzi-Castelan, and Christopher L. Drake
Long-term Efficacy of the Sleep to Prevent Evolving Affective Disorders (SPREAD) Trial as an Internet-based Treatment for Insomnia, Andrea Cuamatzi-Castelan, Philip Cheng, Cynthia Fellman-Couture, G Tallent, K Tran, C A. Espie, Christine LM Joseph, Timothy Roehrs, and Christopher L. Drake
Efficacy of SM-1 in a Transient Insomnia Model, T Dahl, Thomas Roth, M Ahmad, and L Chen
The Pharmacokinetics and Pharmacodynamics of SM-1, T Dahl, Thomas Roth, M Scheinin, J Suopanki-Lalowski, M Valge, A Puhakka, H Mikola, Z Lovró, A Meierjohann, L Vuorilehto, and L Chen
Examining the Effects of Slow-Wave Activity Disruption on Waking EEG Theta Activity, J Goldschmied, Philip Cheng, R Armitage, and P Deldin
Management of Ehlers-Danlos Related OSA with Home Sleep Testing and Auto-CPAP, J Hogaboam, K Moss, and L Bazan
Inability to Discontinue Chronic Hypnotic Use, Gail Koshorek, D Withrow, Thomas Roth, and Timothy Roehrs
The Impact of Treating Insomnia upon Functional Health, Psychological Wellbeing and Sleep-Related Quality of Life: A Randomised Controlled Trial with Mediation Analysis, A Luik, R Emsley, S D. Kyle, C Gordon, Christopher L. Drake, A Marsden, and C A. Espie
Relationship Between Efficacy Endpoints and Measures of Functional Status and Health-Related Quality of Life (HRQoL) in Obstructive Sleep Apnea patients Treated for Excessive Sleepiness, S D. Mathias, R D. Crosby, Christopher L. Drake, M Bron, S Bujanover, D Menno, and K F. Villa
Stress-Related Sleep Reactivity Predicts Peri-Partum Insomnia, Psychopathology and Suicidality, L Palagini, U Moretto, M Novi, D Caruso, and Christopher L. Drake
Markers for Hypnotic Abuse Liability: Cortisol in Insomnia?, Timothy Roehrs, Gail Koshorek, D Withrow, and Thomas Roth
Effectiveness of Recruiting Type 1 Narcolepsy Patients via Internet Based Pre-Selection System, Thomas Roth, S O'Daly, M Fenton, S Dowd, N Cassidy, J Allen, D Monteith, and S Klassen
Treatment of Obstructive Sleep Apnea with Positive Airway Pressure in Mild Cognitive Impairment, Aarushi Suneja, Virginia Skiba, Marina Novikova, Lonni Schultz, and Beth McLellan
Impact of Behavioral Insomnia Treatments on Quality of Life in Post-menopausal Women, G Tallent, Philip Cheng, Cynthia Fellman-Couture, Christine V. Tonnu, K Moss, T Arnedt, and Christopher L. Drake
Impact of Behavioral Insomnia Treatment on Post-Menopausal Female Sexual Functioning, Christine V. Tonnu, Philip Cheng, David A. Kalmbach, Cynthia Fellman-Couture, G Tallent, J Arnedt, Meeta Singh, and Christopher L. Drake
Insomnia and Stress: Associations with Mental Resilience and Mood, J. C. Verster, L. Palagini, M. Mackus, A. J. Van De Loo, J. Garssen, and Thomas Roth
Self-Reported Sleep During Discontinuation of Chronic Hypnotic Use, D Withrow, Gail Koshorek, Thomas Roth, and Timothy Roehrs
Submissions from 2017
Clinical Profile of Suvorexant for the Treatment of Insomnia over 3 Months in Women and Men: Subgroup Analysis of Pooled Phase-3 Data, W J. Herring, K M. Connor, E Snyder, D B. Snavely, Y Zhang, J Hutzelmann, D Matzura-Wolfe, R M. Benca, A D. Krystal, J K. Walsh, C Lines, Thomas Roth, and D Michelson
